Q3 FY26 results approved; no 3rd interim dividend declared
VIDHIING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 and nine month FY26 results ended Dec 31, 2025 on standalone and consolidated basis. Standalone Q3 revenue at Rs 9,445 lakhs, down 4.1 percent YoY. Nine month standalone PAT at Rs 3,580 lakhs, up 13.5 percent YoY. Board skipped 3rd interim dividend. Limited review report by Bhuta Shah and Co LLP was clean with no qualifications.
Mixed: Q3 revenue dipped but 9M PAT grew steadily. Skipped interim dividend may disappoint income-focused investors.